Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
FT596 / Fate Therap
CAR-NK cell therapy FT596 ‘well tolerated’ in phase 1 trial - SOHO Insider
FT596 and FT516 Off-the-shelf, iPSC-derived NK Cell Products Shows ...
FT596 Shows Favorable Tolerability, Response Rate in B-Cell Lymphoma
FT596 Clinical Trial: Insights into Targeted Cell Therapy
Off-the-Shelf NK Cell Products FT596 and FT516 Show Early Promise in B ...
Novel Off-the-Shelf CAR-NK Therapy FT596 Shows Early Promise in B-Cell ...
Fate Therapeutics Announces New Preclinical Data for FT596
NK细胞疗法临床数据公布，长期疗效不及CAR-T 8月19日，Fate Therapeutics 公布了两款NK细胞疗法FT596、FT516 ...
FT596：治疗B细胞恶性肿瘤的CAR-NK-干细胞&免疫细胞&外泌体&再生医学领域垂直媒体细胞世界
#41-Cell and Gene Therapy Today - by Pedro Silva Couto
DISEASE In A DISH | 基于诱导多功能干细胞iPSC来源的药物研发_生物器材网
NK细胞疗法最新临床结果，看即用型细胞疗法的未来… - 知乎
从Fate技术演化看iPS NK/CAR-NK的机会和挑战_细胞_临床_产品
Induced pluripotent stem-cell-derived CD19-directed chimeric antigen ...
BioNews | Fate ：宣布FT516和FT596的积极中期临床数据，针对复发/难... 作者：林出 微信公众号：蹊之美股生物医药 ...
CAR-NK Cells: A Chimeric Hope or a Promising Therapy?
最前沿丨癌症免疫療法「新星」，iPS來源的CAR-NK療法獲批臨床 - 每日頭條
iPSC来源的CAR-NK疗法最新数据发布！“现货型”细胞疗法再添利器医药新闻-ByDrug-一站式医药资源共享中心-医药魔方
iPSC衍生的NK细胞疗法最新进展！Fate公司公布的中期临床试验数据积极丨医麦客 医麦客近期热门报道 ★盛会邀约丨2021溶瘤病毒药物开发 ...
所有患者均产生临床反应！CAR-NK细胞疗法FT596登场，首次人体试验数据惊艳
FT596: Translation of First-of-Kind Multi-Antigen Targeted Off-the ...
Development of CAR-NK cell therapies in the industry. (A) GoCAR-NK ...
FT596: iPSC-derived CAR-NK cells with engineered persistence for B-cell ...
New cell sources for CAR-based immunotherapy - PMC
从hero到zero: FATE砍掉NK管线, 反留一款CAR-T？|NK细胞|疗法|研究|药物|-健康界
NK細胞治療實體瘤新策略，抗體—NK細胞偶聯臨床試驗 | 精準生技股份有限公司
Safety and Efficacy of FT596, a First-in-Class, Multi-Antigen Targeted ...
深度解析CAR-NK疗法的前世今生。什么是CAR-NK？什么是过继细胞免疫治疗(Adoptive Cell Transfer Therapy ...
Frontiers | From CAR-T Cells to CAR-NK Cells: A Developing ...
Current Progress of CAR-NK Therapy in Cancer Treatment
Current strategies exploiting NK‐cell therapy to treat haematologic ...
Emerging NK cell therapies for cancer and the promise of next ...
CAR NK-Cell Therapy Is Quickly Growing in Immunotherapy
Loss of metabolic fitness drives tumor resistance after CAR-NK cell ...
CAR-NK细胞临床试验频传捷报，从血液肿瘤到实体瘤全面狙击|细胞|患者|CAR-NK|肿瘤|淋巴瘤|-健康界
Frontiers | CAR-NK cell therapy: promise and challenges in solid tumors
Frontiers | Advances in CAR-NK cell therapy for hematological malignancies
CAR-NK细胞疗法治疗肠癌、白血病、淋巴瘤等癌种,缓解率超50%_全球肿瘤医生网
CAR-NK cells - by Dr Shilpi - Science Xplained
CAR-NK细胞的临床试验介绍_mAb_抗原_治疗
Fate Therapeutics Announces Positive Interim Clinical Data from its ...
What is CAR-NK therapy & how is it changing cancer research? - Life in ...
Unlocking the Potential of CAR Natural Killer Cell Therapy in ...
Differentiating Induced Pluripotent Stem Cells into Natural Killer ...
盘点2025年CAR-NK细胞疗法四大重磅进展，MRD-CR率100%满分领跑，缓解率创新高_全球肿瘤医生网
前沿：NK细胞疗法进展_Cell_临床_bright
【药海听涛】FATE的困局，细胞治疗的命运？ 上周一条引入瞩目的新闻，曾经光芒万丈的细胞治疗新锐公司$Fate Therapeutics ...
NK细胞“杀疯”癌细胞！肺癌、肝癌、淋巴瘤无处藏，筑牢抗癌先锋第一道防线！ - 知乎
CAR-NK Cell Therapy: A Transformative Approach to Overcoming ...
Ex Vivo Cell Modulation - Fate Therapeutics
NK细胞: 下一代免疫细胞产品的理想候选者|NK细胞|实体瘤|药物|肿瘤|-健康界
Frontiers | Synergistic treatment strategy: combining CAR-NK cell ...
CAR-NK Therapy: An Effective Strategy for Cancer Treatment | Sino ...
Superior Expansion and Cytotoxicity of Human Primary NK and CAR-NK ...
Frontiers | A structural, genetic and clinical comparison of CAR-T ...
Chimeric Antigen Receptor-Engineered Natural Killer (CAR NK) Cells in ...
Frontiers | CAR-NK cells: harnessing the power of natural killers for ...
ReNAP公司|基于mRNA的CAR-NK疗法用于B细胞淋巴瘤治疗 - 知乎
FT576 / Fate Therap
CAR-NK细胞疗法的崛起与未来潜力：超越血液癌症，治疗广泛肿瘤和自身免疫疾病的新希望 - 美国续航教育
54%的r/rB细胞淋巴瘤患者肿瘤显著缩小，其中37%完全消失，CAR-NK细胞疗法FT596公布I期临床研究数据 - 北京凯石国际医疗技术有限公司
Frontiers | CD19-Targeted Immunotherapies for Diffuse Large B-Cell Lymphoma
Frontiers | Taking Lessons from CAR-T Cells and Going Beyond: Tailoring ...
Natural Killer Cells: A Promising Kit in the Adoptive Cell Therapy Toolbox
Frontiers | Highly Efficient Generation of Transgenically Augmented CAR ...
Frontiers | Beyond CAR-T Cells: exploring CAR-NK, CAR-M, and CAR-γδ T ...
CAR-NK开发的技术难点|NK细胞|CAR|肿瘤|抗原|病毒|受体|-健康界
【柳叶刀】诱导多能干细胞来源的CD19 CAR-NK治疗B细胞淋巴瘤的首次人体研究-MedSci.cn
Phenotype of iDuo-MM CAR-NK cells a Flow cytometry analysis of the ...
Fate Therapeutics Plans Trials Testing Off-the-shelf NK Cell Therapy ...
NK 细胞冻存技术迎新进展：推动免疫细胞治疗新时代 - 癌症123
Frontiers | Preclinical and clinical studies of CAR-NK-cell therapies ...
Schematic illustration of a CAR-T or CAR-NK cell therapy, which uses ...
疾病控制率达66.7%！双重改造的CAR-T疗法有望治疗实体瘤；新型CAR-NK细胞疗法公布最新临床数据，总缓解率达100%医药新闻 ...
Frontiers | CAR-NK cell therapy for glioblastoma: what to do next?
02462-0/asset/a9360669-6b00-40c7-bace-6080d60617b5/main.assets/gr1_lrg.jpg)
02462-0/asset/a2ed3c2a-1d79-4e0b-b203-80969770e331/main.assets/gr3.jpg)
